SCHEMBL30663

SCHEMBL30663

COc1ccc2nc(C(O)c3ccc(O[Si](C)(C)C(C)(C)C)c(OC)c3)sc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
TSHR P16473 2/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 3/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
PDK1 Q15118 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39
TUBB8 Q3ZCM7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23661 0.80 TSHR (0.75) GAATSHRMAPK1RAB9AMEN1
SCHEMBL23072 0.77 CYP3A4 (0.45) GAATSHRMAPK1RAB9AMEN1
SCHEMBL31160 0.77 GAA (0.62) GAATSHRMAPK1RAB9AMEN1
SCHEMBL4823200 0.77 DRD2 (0.40) GAATSHRKMT2ACYP1A2CYP2C19
SCHEMBL30666 0.76 HSD17B1 (0.59) GAARAB9AMEN1KMT2AMAPT
SCHEMBL20694277 0.74 GAA (0.47) GAATSHRMAPK1RAB9AKMT2A
SCHEMBL13640332 0.73 CA12 (0.59) GAAMEN1KMT2AMAPTCYP1A2
SCHEMBL45838 0.72 CASR (0.47) GAATSHRRAB9AMEN1KMT2A
SCHEMBL4821120 0.72 ACHE (0.40) GAATSHRKMT2ACYP1A2CYP2C19
SCHEMBL31285 0.72 HSD17B1 (0.51) GAATSHRRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025638-A1 SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS Universität des Saarlandes (DE) 2012-03-01 WO disclosed